C. Jennings

The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease.

R. Quinton, S. Pearce, P. Donaldson, 2004, The Journal of clinical endocrinology and metabolism.

No association of the codon 55 methionine to valine polymorphism in the SUMO4 gene with Graves’ disease

S. Pearce, C. Owen, V. Wilson, 2005, Clinical endocrinology.

A haplotype of the CYP27B1 promoter is associated with autoimmune Addison's disease but not with Graves' disease in a UK population.

S. Pearce, C. Owen, V. Wilson, 2005, Journal of molecular endocrinology.

Role of the CD40 locus in Graves' disease.

S. Pearce, P. Donaldson, P. Perros, 2004, Thyroid : official journal of the American Thyroid Association.

Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML

B. Falini, C. Vetro, H. de Thé, 2021, Leukemia.

The deleted in colorectal carcinoma (DCC) gene 201 R → G polymorphism: no evidence for genetic association with autoimmune disease

J. Heward, S. Gough, T. Merriman, 2003, European Journal of Human Genetics.

Mutational analysis of the FOXP3 gene and evidence for genetic heterogeneity in the immunodysregulation, polyendocrinopathy, enteropathy syndrome.

S. Pearce, H. Imrie, T. Cheetham, 2003, The Journal of clinical endocrinology and metabolism.

Genetic association studies of the FOXP3 gene in Graves' disease and autoimmune Addison's disease in the United Kingdom population.

S. Pearce, T. Cheetham, C. Owen, 2006, Journal of molecular endocrinology.